Baring Asset Management’s AbbVie ABBV Stock Holding History

Baring Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-83,910	Closed	-$5.29M	–	179
2016 Q3	$5.29M	Sell	83,910 -9,762	-10%	-$632K	0.38%	77
2016 Q2	$5.8M	Sell	93,672 -25,701	-22%	-$1.57M	0.47%	68
2016 Q1	$6.82M	Sell	119,373 -14,743	-11%	-$822K	0.57%	58
2015 Q4	$7.95M	Sell	134,116 -11,075	-8%	-$638K	0.68%	51
2015 Q3	$7.9M	Sell	145,191 -10,439	-7%	-$680K	0.72%	53
2015 Q2	$10.5M	Sell	155,630 -33,794	-18%	-$2.21M	0.86%	38
2015 Q1	$11.1M	Buy	189,424 +50,757	+37%	+$3.07M	0.88%	43
2014 Q4	$9.07M	Buy	138,667 +37,865	+38%	+$2.39M	0.58%	64
2014 Q3	$5.82M	Buy	+100,802	New	+$5.6M	0.34%	78

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Baring Asset Management's ABBV Position: Q4 2016 in Review

Baring Asset Management sold out of AbbVie (ABBV) in Q4 2016, closing a stake of 83,910 shares — an estimated $5.29M sold.

Baring Asset Management first reported a position in ABBV in Q3 2014 and held it in 9 quarters. The position peaked at $11.1M in Q1 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

Baring Asset Management reported no remaining AbbVie position as of Q4 2016 after selling out during the quarter.
Baring Asset Management sold 83,910 AbbVie shares in Q4 2016, an estimated $5.29M.
Baring Asset Management first reported a position in AbbVie in Q3 2014 and held it in 9 quarters.
Baring Asset Management's AbbVie position peaked at $11.1M in Q1 2015.
1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Baring Asset Management's 13F filing for Q4 2016, filed 27 Jan 2017.